Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

467 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort.
Soria A, Fava M, Bernasconi DP, Lapadula G, Colella E, Valsecchi MG, Migliorino GM, D'Ambrosio R, Landonio S, Schiavini M, Spinetti A, Carriero C, Degasperi E, Cologni G, Gatti F, Viganò P, Hasson H, Uberti-Foppa C, Pasulo L, Baiguera C, Rossotti R, Vinci M, Puoti M, Giorgini A, Menzaghi B, Lombardi A, Pan A, Aghemo A, Grossi PA, Boldizzoni R, Colombo S, Viganò M, Rumi MG, Del Poggio P, Valenti L, Giglio O, De Bona A, d'Arminio Monforte A, Colombo A, Spinelli O, Pigozzi MG, Molteni C, Bonfanti P, Terreni N, Perini P, Capretti A, Bella D, Liani C, Polo S, Aimo G, Pagnucco L, Bhoori S, Centenaro R, Graffeo M, Ciaccio A, Dionigi E, Lazzaroni S, Carderi I, Di Marco M, Rizzardini G, Noventa F, Lampertico P, Fagiuoli S. Soria A, et al. Among authors: puoti m. Liver Int. 2020 Apr;40(4):769-777. doi: 10.1111/liv.14386. Epub 2020 Feb 3. Liver Int. 2020. PMID: 31970845
Decrease of HCVRNA after three days of daily interferon treatment is predictive of the virological response at one month.
Magalini A, Puoti M, Putzolu V, Quiros-Roldan E, Forleo MA, Rossi S, Zaltron S, Spinetti A, Zanini B, Zonaro A, Solfrini R, Carosi G. Magalini A, et al. Among authors: puoti m. J Clin Lab Anal. 2000;14(3):120-4. doi: 10.1002/(sici)1098-2825(2000)14:3<120::aid-jcla6>3.0.co;2-#. J Clin Lab Anal. 2000. PMID: 10797610 Free PMC article. Clinical Trial.
Mortality for liver disease in patients with HIV infection: a cohort study.
Puoti M, Spinetti A, Ghezzi A, Donato F, Zaltron S, Putzolu V, Quiros-Roldan E, Zanini B, Casari S, Carosi G. Puoti M, et al. J Acquir Immune Defic Syndr. 2000 Jul 1;24(3):211-7. doi: 10.1097/00126334-200007010-00003. J Acquir Immune Defic Syndr. 2000. PMID: 10969344
Pilot dose-finding trial on interferon alpha in combination with ribavirin for the treatment of chronic hepatitis C in patients not responding to interferon alone.
Puoti M, Cadeo GP, Putzolu V, Forleo MA, Barni MC, Cristini G, Rossi S, Spinetti A, Zaltron S, Zanini B, Quiros-Roldan E, Paraninfo G, Gargiulo F, Carosi G. Puoti M, et al. Dig Liver Dis. 2001 Mar;33(2):163-72. doi: 10.1016/s1590-8658(01)80073-6. Dig Liver Dis. 2001. PMID: 11346146 Clinical Trial.
[Treatment of HCV infection in HIV-positive patients].
Puoti M, Zanini B, Baiguera C, Bella D, Prestini K, Milesi L, Antonini MG, Carosi G. Puoti M, et al. Recenti Prog Med. 2001 Oct;92(10):618-23. Recenti Prog Med. 2001. PMID: 11695308 Review. Italian.
467 results